Guangdong Biolight Meditech Co., Ltd.
Shenzhen Stock Exchange 300246.SZ
Guangdong Biolight Meditech Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 1.37
Guangdong Biolight Meditech Co., Ltd. Price to Sales Ratio (P/S) is 1.37 on January 14, 2025, a -37.85% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
-
Guangdong Biolight Meditech Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 12.44 on December 20, 2024, which is 806.16% above the current Price to Sales Ratio (P/S).
-
Guangdong Biolight Meditech Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 1.18 on February 07, 2024, which is -14.36% below the current Price to Sales Ratio (P/S).
-
Guangdong Biolight Meditech Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.55.
Key data
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
Market news
Loading...
Shenzhen Stock Exchange: 300246.SZ
| CEO | Mr. Jinyuan Yan |
| IPO Date | July 19, 2011 |
| Location | China |
| Headquarters | No. 2 Innovation First Road |
| Employees | 1,419 |
| Sector | Health Care |
| Industries | |
Description
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG machines, fetal monitors, hemodialysis products, homecare medical products, medical pumps, veterinary monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. Guangdong Biolight Meditech Co., Ltd. was founded in 1993 and is headquartered in Zhuhai, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email